News and Trends 17 Feb 2023
Positive results for INOVIO recurrent respiratory papillomatosis trial
INOVIO Pharmaceuticals has announced positive preliminary results from the second cohort of its phase 1/2 clinical trial evaluating INO-3107 for the treatment of HPV 6 and HPV 11-associated recurrent respiratory…